IPO
Galapagos NV announced that its board of directors created 2,070,000 warrants under new warrant plans for the benefit of the employees, directors, and a consultant of the company and its subsidiaries.
Pharming has acquired its shareholding through the conversion of €2.5 million of existing credits and €1.6 million of new cash subscription for a total of €4.1 million in BioConnection shares, plus additional shares acquired from existing investors.
A summary of IPOs from companies in the biotech and pharma world since April 1, 2019.
The shares are trading on XETRA, the electronic trading platform of Deutsche Börse.
Conference call scheduled for Tuesday April 2nd , 2019, 11:00am Eastern time, 8:00am Pacific Time
GLG Life Tech Corporation, a global leader in the agricultural and commercial development of high-quality zero-calorie natural sweeteners, announces financial results for the three and twelve months ended December 31, 2018.
Evotec SE announced that it has completed its conversion into a company under European law with its registration in the commercial register of the District Court of Hamburg.
Funding to drive investigation of further potential indications for lead product candidate, KarXT First U.S. Patent awarded for KarXT
TLC announced financial results for the fourth quarter and full year ended December 31, 2018, and provided a business update.
Galapagos NV published its annual report for the financial year 2018.
PRESS RELEASES